Skip to main content
. 2023 Feb 2;43(1):17-24. doi: 10.5144/0256-4947.2023.17

Table 2.

Basic characteristics in patients by state of hyponatremia.

Dilutional Hyponatremia (n=182) Depletional Hyponatremia (n=142) P value
Male 58 (31.9) 69 (48.6) .003
Age >70 years 144 (79.1) 89 (62.7) .002
Diabetes 61 (33.5) 39 (27.5) .294
Chronic kidney disease 68 (37.4) 29 (20.6) .002
Chronic obstructive pulmonary diseases 19 (10.4) 18 (12.7) .651
Pulse (beats/min) 82.6 (23.3) 88.5 (22.3) .022
Body mass index (kg/m2) 20.6 (3.5) 21.0 (3.8) .332
Systolic blood pressure (mmHg) 125.1 (23.8) 118.5 (22.1) .012
Diastolic blood pressure (mmHg) 71.4 (13.7) 71.5 (12.4) .957
Left ventricular ejection fractions (%) 52 (41-62) 49 (38-60) .744
Hemoglobin (g/dL) 9.6 (2.0) 13.8 (1.6) <.001
Alanine aminotransferase (U/L) 17 (12-28) 21 (15-36) .005
Albumin (g/L) 34.5 (5.6) 38.0 (4.9) <.001
Creatinine (mg/dL) 1.59 (1.12) 1.16 (0.68) <.001
Uric acid (mg/dL) 8.94 (3.54) 8.37 (3.15) .133
Potassium (mmol/L) 4.36 (1.01) 4.25 (0.77) .300
Triglyceride (mmol/L) 0.92 (0.68-1.24) 1.00 (0.74-1.34) .186
Total cholesterol (mmol/L) 3.36 (1.07) 4.02 (1.14) <.001
High density lipoprotein cholesterol (mmol/L) 1.00 (0.37) 1.13 (0.41) .005
Low density lipoprotein cholesterol (mmol/L) 1.59 (0.65) 2.09 (0.77) <.001
Fibrinogen (g/L) 3.46 (1.20) 3.58 (1.32) .408
B-type natriuretic peptide (pg/mL) 695 (334-1902) 593 (163-1514) .032
Angiotensin converting enzyme inhibitors 58 (31.9) 54 (38.0) .299
Intravenous diuretic use 161 (88.5) 128 (90.1) .762

Data are n (%), mean (standard deviation) or median (interquartile range)